Compounds > aztreonam

aztreonam and streptomycin

aztreonam has been researched along with streptomycin in 12 studies

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19901 (8.33)18.7374
1990's0 (0.00)18.2507
2000's3 (25.00)29.6817
2010's7 (58.33)24.3611
2020's1 (8.33)2.80

Authors

AuthorsStudies
Adams, J; de Oliveira Garcia, D; Doi, Y; Paterson, DL1
Lombardo, F; Obach, RS; Waters, NJ1
Carattoli, A; Ellington, MJ; Karisik, E; Livermore, DM; Underwood, A; Woodford, N1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ1
Bogaerts, P; Buvens, G; Glupczynski, Y; Lauwers, S; Piérard, D1
Ekins, S; Williams, AJ; Xu, JJ1
Bellera, CL; Bruno-Blanch, LE; Castro, EA; Duchowicz, PR; Goodarzi, M; Ortiz, EV; Pesce, G; Talevi, A1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
DePaoli, A; Keim, GR; Myhre, JL1
Dan, LA; Lim, RL; Ngu, DY; Ooi, A; Wong, A1
Chen, H; Dai, L; Hou, D; Li, T; Long, X; Sun, C; Wang, Y; Xiong, Z1

Reviews

1 review(s) available for aztreonam and streptomycin

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

11 other study(ies) available for aztreonam and streptomycin

ArticleYear
Coproduction of novel 16S rRNA methylase RmtD and metallo-beta-lactamase SPM-1 in a panresistant Pseudomonas aeruginosa isolate from Brazil.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:3

    Topics: Amino Acid Sequence; Aminoglycosides; beta-Lactamases; Brazil; Carbapenems; Cloning, Molecular; Drug Resistance, Multiple, Bacterial; Methyltransferases; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Pseudomonas aeruginosa; Pseudomonas Infections

2007
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Complete nucleotide sequences of plasmids pEK204, pEK499, and pEK516, encoding CTX-M enzymes in three major Escherichia coli lineages from the United Kingdom, all belonging to the international O25:H4-ST131 clone.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:10

    Topics: beta-Lactamases; Computational Biology; Escherichia coli; Models, Genetic; Molecular Sequence Data; Open Reading Frames; Plasmids; United Kingdom

2009
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Developing structure-activity relationships for the prediction of hepatotoxicity.
    Chemical research in toxicology, 2010, Jul-19, Volume: 23, Issue:7

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes

2010
Antimicrobial resistance testing of verocytotoxin-producing Escherichia coli and first description of TEM-52 extended-spectrum β-lactamase in serogroup O26.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:11

    Topics: Adhesins, Bacterial; Anti-Bacterial Agents; beta-Lactamases; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Proteins; Humans; Plasmids; Shiga Toxins

2010
A predictive ligand-based Bayesian model for human drug-induced liver injury.
    Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:12

    Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands

2010
Prediction of drug intestinal absorption by new linear and non-linear QSPR.
    European journal of medicinal chemistry, 2011, Volume: 46, Issue:1

    Topics: Humans; Intestinal Absorption; Linear Models; Molecular Conformation; Nonlinear Dynamics; Permeability; Pharmaceutical Preparations; Probability; Quantitative Structure-Activity Relationship; Thermodynamics

2011
Ototoxicity of subcutaneously administered aztreonam in neonatal rats.
    Toxicology and applied pharmacology, 1985, Volume: 77, Issue:1

    Topics: Animals; Animals, Newborn; Anti-Bacterial Agents; Aztreonam; Body Weight; Ear Diseases; Female; Injections, Subcutaneous; Male; Motor Activity; Organ of Corti; Rats; Streptomycin

1985
Detection of antibiotic resistance in probiotics of dietary supplements.
    Nutrition journal, 2015, Sep-14, Volume: 14

    Topics: Aztreonam; Bacteria; Ciprofloxacin; Dietary Supplements; Drug Resistance, Bacterial; Food Microbiology; Gentamicins; Lactobacillus; Pilot Projects; Probiotics; Streptomycin; Vancomycin

2015
Pathogenicity and transcriptome analysis of a strain of Vibrio owensii in Fenneropenaeus merguiensis.
    Fish & shellfish immunology, 2022, Volume: 130

    Topics: Ampicillin; Animals; Anti-Bacterial Agents; Aztreonam; Cefazolin; Cefotaxime; Ciprofloxacin; Citrates; Gene Expression Profiling; Immunity, Innate; Lectins, C-Type; Minocycline; Oxacillin; Penaeidae; Phosphatidylinositol 3-Kinases; Piperacillin; Proto-Oncogene Proteins c-akt; Pyruvates; Streptomycin; Transcriptome; Vibrio; Virulence

2022